Viking Therapeutics stock jumps more than 15% on promising weight loss pill data – CNBC

Viking Therapeutics stock jumps more than 15% on promising weight loss pill data CNBC
Viking Therapeutics stock rises on positive oral obesity drug Phase 1 data Yahoo Finance
Viking Therapeutics Posts Promising Weight-Loss Data as Cost Worries Escalate Barron’s

Brought to you by Google News. Read the rest of the article here.